Gynecology Surgical Forceps Market Seen Reaching $17.44B by 2030

The gynecology surgical forceps market is projected to grow from $12.95 billion in 2025 to $17.44 billion by 2030, driven by more gynecological surgeries, minimally invasive procedures and rising demand for outpatient care. North America led the market in 2025, while Asia-Pacific is expected to post the fastest growth.

Why it matters: - Demand for gynecology surgical forceps is rising as hospitals and outpatient centers handle more gynecological procedures. - The market outlook points to continued spending on specialized surgical tools tied to women’s health and cancer care. - Growth in reusable, ergonomic and infection-control-focused instruments signals what buyers are prioritizing.

What happened: - The Business Research Company released a report on the gynecology surgical forceps market with forecasts through 2030. - The market is estimated at $12.95 billion in 2025 and is projected to reach $13.81 billion in 2026. - The report forecasts the market will hit $17.44 billion by 2030, implying a 6.0% CAGR over the period. - The press release also cites 6.6% CAGR growth from 2025 to 2026. - The report says North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - Download a free sample of the report - View the full market report

The details: - The report ties recent market growth to higher rates of gynecological surgeries, improved hospital infrastructure, more gynecological disorders, greater awareness of women’s healthcare and more skilled surgical professionals. - Future growth is linked to wider use of minimally invasive gynecological procedures. - More outpatient and day-care surgeries are also expected to support demand. - The report points to increased investment in women’s health services. - Expansion of ambulatory surgical centers is another growth driver. - Demand for affordable surgical instruments is expected to rise. - The report highlights a shift toward precision-focused and ergonomic forceps. - Reusable and sterilizable tools are gaining preference. - Infection control and patient safety are becoming stronger purchasing priorities. - Gynecology surgical forceps are designed to grasp, hold, manipulate or remove tissue and other materials during gynecological surgery. - The instruments come in different forms and sizes for tasks such as clamping blood vessels, handling tissue delicately and retrieving surgical objects.

Between the lines: - The cancer data in the release suggests a broader clinical tailwind, not just routine surgical demand. - The American Cancer Society estimated uterine cervix cancer deaths at 4,280 in 2022 and 4,310 in 2023. - Deaths from vaginal and other female genital cancers rose from 1,630 in 2022 to 1,740 in 2023. - Those figures reinforce the need for precise tools in surgeries involving cancers of the uterus, cervix and vagina. - The emphasis on outpatient settings suggests care is moving away from traditional inpatient-only procedures.

What's next: - The market is expected to keep expanding as minimally invasive procedures and outpatient surgeries become more common. - Product development will likely continue to center on ergonomics, sterilization and infection prevention. - Regional growth should remain strongest in Asia-Pacific if healthcare investment and surgical capacity continue to rise.

The bottom line: - Gynecology surgical forceps are a niche but growing surgical category, with long-term demand supported by cancer incidence, outpatient care expansion and women’s health investment.